uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted April 15, 2003

FTC Requires Scientific Evidence for "Snore Formula" Claims

On April 15 2003, the U.S. Federal Trade Commission (FTC) announced that an Arizona-based company, Snore Formula, Inc., its officers, and a distributor have agreed to settle FTC charges that they failed to have scientific substantiation for the claims made for "Dr. Harris' Original Snore Formula" (Snore Formula) tablets. Snore Formula is an herbal supplement purported to cure snoring. The Commission's complaint charges that the respondents made unsubstantiated claims about the tablets' efficacy in preventing sleep apnea in adult and child users and significantly reducing snoring. The Commission accepted the consent agreement subject to public comment. It requires that the respondents possess competent and reliable scientific evidence to substantiate representations that Snore Formula or any other food, drug, device, service, or dietary supplement prevents, treats, eliminates, or reduces snoring and sleep apnea in both adult or child users.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at